The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.
0 Comments Click here to read/write comments
Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball
Each year members of the industry gather together at Dpharm — a conference which challenges attendees to question how we, as an industry, can disrupt clinical research to reduce the burden to patients and physicians. This year's event will be held virtually September 28-29 and will focuses on making innovation stick in a post-COVID world.
0 Comments Click here to read/write comments
Topics: Disruptive Innovation, Conferences, Study Voices, DPHARM, Surveys, Danielle Frate, Alexia Medici, Decentralized Clinical Trials
PHARMA15 LIVE!
Coordination to Creation: Initiating a New Study Partnership
We often hear about unburdening patients and site staff during clinical trial participation – but what about unburdening sponsors during the clinical trial lifecycle? As BBK Worldwide® Creative Director for Strategic Services, I assist in prescribing the programs and services that best align with the protocol to support a study’s participants on an individual basis. From there, my team and I work closely with our account executives to seamlessly bring our full-service study support from proposal to coordination to creation.
0 Comments Click here to read/write comments
Topics: Pharma15 Live!, Danielle Frate, Alexia Medici